← Back to catalogue

RHA® Redensity

FDA UDI

Class III (US FDA UDI)

by Teoxane SA

Identity

Trade Name
RHA® Redensity FDA UDI
Generic Name
Dermal tissue reconstructive material, microbe-derived, anaesthetic FDA UDI
Device Name
"One box of RHA® Redensity contains two blisters and one instruction for use. Each blister contains a 1mL prefilled syringe and two needles (30G 1/2). Box Packaging (ID 07640173230083) is defined as unit of sales and identified with a serial number." FDA UDI
Model / Reference
RHA® Redensity US 1ml Schott/2 aig. Terumo TW30G1/2 FDA UDI
Description
"One box of RHA® Redensity contains two blisters and one instruction for use. Each blister contains a 1mL prefilled syringe and two needles (30G 1/2). Box Packaging (ID 07640173230083) is defined as unit of sales and identified with a serial number." FDA UDI

Identifiers

Catalog Number
940056 FDA UDI
Primary DI / UDI-DI
07640173231653 FDA UDI
FDA Product Code
LMH FDA UDI
GMDN Term
Dermal tissue reconstructive material, microbe-derived, anaesthetic FDA UDI

Classification

Device Class
Class III FDA UDI
Commercial Distribution
Not in Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

Yes

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

RHA® Redensity by Teoxane SA — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Teoxane SA

Sources (1)

  • FDA UDI 6044fc7b-adc1-431b-9f9d-d1fb1aaee839 37 fields · synced Jun 1, 2026